Tarsus Pharmaceuticals, Inc. TARS

Latest FY: 2025 Healthcare Biotechnology
Market Price $81.10
Market Cap $3.49B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑146.7% YoY
$451.36M
3-Yr CAGR: 159.5%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑73.6% YoY
-$22.31M
FCF Yield: -0.64%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TARS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $-0.0M $-3.7M $-3.8M
FY 2020 +100.0% 0.00% $-21.1M $-21.6M -461.2%
FY 2021 $57.0M $57.0M 0.00% $3.7M $3.2M +114.6%
FY 2022 $25.8M -54.7% $23.6M 0.00% $-49.0M $-49.5M -1,666.6%
FY 2023 $17.4M -32.4% $14.1M 0.00% $-117.5M $-119.0M -140.2%
FY 2024 $183.0M +948.6% $170.1M 0.00% $-83.0M $-84.6M +28.9%
FY 2025 $451.4M +146.7% $420.7M 0.00% $-12.5M $-22.3M +73.6%
$

Valuation

Market Price $81.10
Market Cap $3.49B
Enterprise Value $3.38B
P/E Ratio N/A
P/B Ratio 10.16
FCF Yield -0.64%
Dividend Yield N/A
Shares Outstanding 43,024,000
%

Profitability & Margins

Gross Margin 93.20%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.80x
Revenue 3-Yr CAGR 159.54%
🛡️

Financial Health & Liquidity

Current Ratio 3.85
Cash Ratio 1.35
Debt / Equity 0.211
Debt / Assets 0.129
Cash & Equivalents $183.64M
Total Debt $72.44M
Book Value / Share $7.98
💧

Cash Flow Efficiency

Operating Cash Flow -$12.45M
Capital Expenditures (CapEx) $9.86M
Free Cash Flow -$22.31M
OCF / Revenue -2.76%
FCF / Revenue -4.94%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $7.98
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $562.16M
Total Liabilities $218.73M
Stockholders' Equity $343.43M
Current Assets $522.78M
Current Liabilities $135.69M